U.S Bank CEO speaks in Santa Barbara
Banking & Finance, Banking Industry, Latest newsSometimes, uncertainty is a good thing. That was one view from Richard K. Davis, the head of U.S. Bank, as he spoke in Montecito on Jan. 11 Davis is the president of the Federal Advisory Council of bankers that consults with the board of governors of the Federal Reserve System. He said he has often Read More →
Amgen inks $180M nanomedicine deal
Banking & Finance, Latest news, Tri-County Public CompaniesThousand Oaks-based Amgen has entered a deal to pay up to $180.5 million for nanomedicine tumor treatments being developed by a Massachusetts company. Cambridge-based Bind Biosciences said it has entered a development agreement with Amgen for its kinase inhibitor nanomedicines for treating a range of solid tumors. The medicines are highly targeted and can be Read More →
Nexsan sold for $120M
Banking & Finance, Latest news, TechnologyThousand Oaks-based Nexsan Corp., a maker of hard-disk storage arrays for mid-sized businesses, has been purchased by Imation Corp. for $120 million. Imation will pay $105 million in cash and 3.3 million common shares, worth about $15 million, for the Thousand Oaks firm. Nexsan is privately held but kicked off an unsuccessful bid to go Read More →
CalAmp buys Wireless Matrix for $53M
Banking & Finance, Latest news, Technology, Tri-County Public CompaniesOxnard-based wireless products company CalAmp Corp. said Dec. 20 that it is buying the U.S. operations of Wireless Matrix Corp. for $53 million in cash. CalAmp said it expects the deal, which will likely close in the first quarter of 2013, to be accretive to its non-GAAP earnings starting in 2014. Wireless Matrix is a Read More →
QAD buys Michigan firm for $5M
Banking & Finance, Latest news, Technology, Tri-County Public CompaniesSanta Barbara-based manufacturing software firm QAD said Dec. 31 that it purchased Michigan-based Cebos for $5 million in cash. QAD sells planning and management software used by large manufacturing firms around the world. Cebos provides management and regulatory compliance software. QAD will pay $3.5 million upon closing the deal and then $1.5 million subject to Read More →
Amgen to pay $150M for misbranding Aranesp
Latest news[Editor’s note: This story has been updated with comments from Amgen.] Biotech giant Amgen pleaded guilty Dec. 18 to a misdemeanor charge for misbranding its anemia drug Aranesp. According to a report from Bloomberg News, the Thousand Oaks-based firm agreed to pay $150 million in fines and penalties as part of the guilty plea. U.S. Read More →
Amgen buys DeCode Genetics for $415M
Banking & Finance, Latest news, Technology, Tri-County Public CompaniesBiotech giant Amgen is buying Icelandic genetics research firm DeCode Genetics for $415 million, the Thousand Oaks company said Dec. 10. The all-cash deal is expected to close before the end of the year and will give Amgen, the largest biotechnology firm in the world, opportunities to develop new medicines that target defective DNA. “DeCode Read More →
